rais ep estim reflect upsid
off-set higher assum tax rate per manag guidanc
boost forecast base slightli
lower assum tax rate though compani solid third quarter organ
growth segment margin improv give us increas confid
meet exceed estim reiter buy rate price
target reflect assum ebitda estim
billion still discount peer current year multipl fig
willi tower watson report adjust ep ahead
estim street mean lower tax rate ad
bottom line total revenu billion essenti line
consensu foreign currenc million top-line headwind
nomin bottom-lin impact company-wid organ growth
roughli doubl mean outlook notabl result difficult
compani also revers last quarter margin declin
segment gener gain quarter aggreg
segment increas bp manag restrain expens
growth
incom million tailwind quarter versu last year
benefit fx pension incom net after-tax adjust
impact per share
manag boost full-year ep guidanc
prior rang larg favor shift
tax guidanc previous lower forecast
incorpor one-tim account chang headwind approxim
per share exclud guidanc
look farther ahead compani gener target double-digit
ep growth specif anticip least bp margin
improv manag also look activ
human capit benefit hcb gener organ increas
growth across geographi organ health
benefit boost global benefit appoint increas
advisori work specialti product reward laggard last
quarter return revenu growth retir revenu advanc slightli
technolog administr solut flat manag point
tr target
higher interest rate gener tailwind profit bulk lump
sum work per note increas pt cleaner stori improv
segment margin point compar
corpor risk broke compani saw top-line acceler organ
immediately-preced second quarter north america region gener
solid growth off-set declin great britain result issu london market
organ result especi consid healthi segment gain put compani
posit in-lin better peer recent quarter despit exposur london
manag highlight unusu weak particularli term market-deriv incom
oper margin crb compar last year
invest risk reinsur irr standout quarter organ revenu
expans sharp improv organ compani saw particular strength
wholesal max matthiessen
irr segment oper profit versu year-ago period
benefit deliveri administr bda organ compar organ
increas last quarter manag attribut gain expand client base along new
membership enrol across busi enrol increas quarter
outlook favor base strong middl market enterpris demand compani
sign addit client total live mid-market sale season still
segment oper margin
forward commentari larg favor free cash flow strong though
full year million prior guidanc influenc number factor includ
million higher capital-expenditure million said expect temporari phenomena
interfer achiev compani goal cash gener equal
ebitda next year specif manag anticip signific growth free cash flow
manag discuss gener outlook addit bp margin improv
may even higher compani also benefit absenc
certain non-recur transit expens relat current revenu recognit standard
impact
term tax rate manag point normal level
compani provid specif outlook conjunct earn call
page
page
million except per share data
salari benefit
updat
requir disclosur last tab workbook
interest earn associ net tax
compani file strh estim
result restat use pro-forma result impact certain line item explicitli restat compani
price
page
advisori brokerag compani offer servic world-wide divid
oper four busi segment corpor risk broke exchang solut
capit benefit invest risk reinsur origin found base
london compani formerli known willi group hold plc chang name
januari acquir tower watson co
buy rate predic opinion compani continu drive margin expans
cost reduct top-lin growth cross-sel well expand health
exchang opportun given uncertainti space also believ compani benefit
short-term tailwind emerg interest cyber secur coverag earli client
win
valuat risk
price target current trade ev ebitda multipl
peer financi out-performance next sever year could result multipl
expans cross-sel potenti view allow outperform
brokerag consult peer new experienc senior leadership team
price target assum stock trade next year ebitda
risk may achiev price target unsuccess integr tower watson
 co also insur price may improv make difficult compani gener
posit organ growth addit tw risk includ declin asset price
could reduc amount pension benefit asset affect health compani client
signific decreas demand consult actuari servic result
chang econom condit factor may also affect stock
mark hugh herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express specif
recommend report
